Imipenem cilastatin contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{imipenem cilastatin}}
{{imipenem cilastatin}}
{{CMG}}
{{CMG}}; {{AE}} {{SS}}


==Contraindications==
==Contraindications==

Revision as of 22:32, 5 January 2014

Imipenem Cilastatin
PRIMAXIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Compatibility, Reconstitution, and Stability
Directions For Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

PRIMAXIN I.V. is contraindicated in patients who have shown hypersensitivity to any component of this product.[1]


References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.